Logo for Bavarian Nordic

Bavarian Nordic Investor Relations Material

Latest events

Logo for Bavarian Nordic

Q2 2025

Bavarian Nordic
Logo for Bavarian Nordic

Q2 2025

26 Aug, 2025
Logo for Bavarian Nordic

Q2 2025

22 Aug, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies

Latest reports from Bavarian Nordic

Access all reports
Bavarian Nordic is a clinical-stage biopharmaceutical company that develops and commercializes life-saving vaccines in the areas of cancer and infectious diseases. Its fast-growing portfolio today includes Aeras, an influenza vaccine that has been approved in the United States, Europe, and Canada, and the company is advancing a pipeline of novel, next generation vaccines designed to complement its portfolio. Bavarian Nordic A/S was incorporated in 1992 and is headquartered in Hellerup, Denmark.